Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Kedar

Showing results (41-50 of 64) with videos related to

Pageof 7
Sort By:
Journal of Biological Response Modifiers|October 1, 1984
Intralesional injection of interleukin-2-expanded autologous lymphocytes in melanoma and breast cancer patients: a pilot studyA Adler, J A Stein, E Kedar, et al.
Transplantation|August 1, 1986
Bone marrow transplantation with T-cell-depleted grafts. I. Reconstitution of immunohemopoietic functions in lethally irradiated mice transplanted with unseparated or T-cell-depleted syngeneic bone marrow graftsM Shalit, M Ayalon, L Weiss, et al.
Journal of Immunological Methods|September 23, 1998
Cytokine production in human mixed leukocyte reactions performed in serum-free mediaA Bishara, R Malka, C Brautbar, et al.
The Journal of Biological Chemistry|July 25, 1985
Cell cycle-dependent regulation of eukaryotic DNA methylase levelM Szyf, F Kaplan, V Mann, et al.
Pharmaceutical Research|March 1, 1996
Preparation and characterization of doxorubicin-loaded sterically stabilized immunoliposomesN Emanuel, E Kedar, E M Bolotin, et al.
Pharmaceutical Research|June 1, 1996
Targeted delivery of doxorubicin via sterically stabilized immunoliposomes: pharmacokinetics and biodistribution in tumor-bearing miceN Emanuel, E Kedar, E M Bolotin, et al.
Cellular Immunology|April 15, 1988
Lysis of murine macrophages infected with intracellular pathogens by interleukin 2-activated killer (LAK) cells in vitroM Resnick, N Roguel, H Bercovier, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 1999
Enhancement of antitumor activity of polyethylene glycol-coated liposomal doxorubicin with soluble and liposomal interleukin 2A Cabanes, S Even-Chen, J Zimberoff, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 25, 2000
Delivery of cytokines by liposomes: hematopoietic and immunomodulatory activity of interleukin-2 encapsulated in conventional liposomes and in long-circulating liposomesE Kedar, H Gur, I Babai, et al.
Progress in Clinical and Biological Research|January 1, 1976
Immunogenicity of tumor cells modified by trinitrobenzene suflonic acid (TNBS)E Kedar, E Unger, N Galili, et al.
Pageof 7

Showing results (41-50 of 64) with videos related to

Sort By:
Pageof 7
Journal of Biological Response Modifiers|October 1, 1984
Intralesional injection of interleukin-2-expanded autologous lymphocytes in melanoma and breast cancer patients: a pilot studyA Adler, J A Stein, E Kedar, et al.
Transplantation|August 1, 1986
Bone marrow transplantation with T-cell-depleted grafts. I. Reconstitution of immunohemopoietic functions in lethally irradiated mice transplanted with unseparated or T-cell-depleted syngeneic bone marrow graftsM Shalit, M Ayalon, L Weiss, et al.
Journal of Immunological Methods|September 23, 1998
Cytokine production in human mixed leukocyte reactions performed in serum-free mediaA Bishara, R Malka, C Brautbar, et al.
The Journal of Biological Chemistry|July 25, 1985
Cell cycle-dependent regulation of eukaryotic DNA methylase levelM Szyf, F Kaplan, V Mann, et al.
Pharmaceutical Research|March 1, 1996
Preparation and characterization of doxorubicin-loaded sterically stabilized immunoliposomesN Emanuel, E Kedar, E M Bolotin, et al.
Pharmaceutical Research|June 1, 1996
Targeted delivery of doxorubicin via sterically stabilized immunoliposomes: pharmacokinetics and biodistribution in tumor-bearing miceN Emanuel, E Kedar, E M Bolotin, et al.
Cellular Immunology|April 15, 1988
Lysis of murine macrophages infected with intracellular pathogens by interleukin 2-activated killer (LAK) cells in vitroM Resnick, N Roguel, H Bercovier, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 1999
Enhancement of antitumor activity of polyethylene glycol-coated liposomal doxorubicin with soluble and liposomal interleukin 2A Cabanes, S Even-Chen, J Zimberoff, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 25, 2000
Delivery of cytokines by liposomes: hematopoietic and immunomodulatory activity of interleukin-2 encapsulated in conventional liposomes and in long-circulating liposomesE Kedar, H Gur, I Babai, et al.
Progress in Clinical and Biological Research|January 1, 1976
Immunogenicity of tumor cells modified by trinitrobenzene suflonic acid (TNBS)E Kedar, E Unger, N Galili, et al.
Pageof 7